ALLMedicine™ Eosinophilic Fasciitis Center
Research & Reviews 128 results
https://doi.org/10.1016/j.nmd.2022.05.009
Neuromuscular Disorders : NMD; Yamazaki H, Matsui N et. al.
Jun 8th, 2022 - Eosinophilic fasciitis (EF) is a rare disorder characterized by muscle stiffness mimicking other neuromuscular diseases. The diagnosis of EF is made on the basis of typical skin lesions. We report a case of a 36-year-old male patient with suspecte...
https://doi.org/10.1080/1744666X.2022.2078309
Expert Review of Clinical Immunology; Naschitz JE
May 17th, 2022 - Clinical guide to eosinophilic fasciitis: straddling dermatology and rheumatology.|2022|Naschitz JE,|
https://doi.org/10.1136/bcr-2021-248707
BMJ Case Reports; Le Q, Robinson A et. al.
Apr 8th, 2022 - Dystrophic calcinosis cutis can be associated with severe pain, decreased mobility, increased risk of infection and significantly decreased quality of life. We report a case of recalcitrant calcinosis cutis on the background of eosinophilic fascii...
https://doi.org/10.1684/ejd.2021.4173
European Journal of Dermatology : EJD; Kromer C, Mitterlechner L et. al.
Feb 3rd, 2022 - Generalized morphea and eosinophilic fasciitis are difficult-to-treat inflammatory and sclerosing skin diseases. Few cases have been reported in which intravenous immunoglobulins were of benefit, possibly owing to their immunomodulatory and antifi...
https://doi.org/10.1111/1756-185X.14284
International Journal of Rheumatic Diseases; Watanabe S, Kondo M et. al.
Jan 14th, 2022 - We report a case of eosinophilic fasciitis triggered by strenuous physical activity, which did not relapse during the follow-up period. We ascertained that interleukin-33 (IL-33) was released from the vascular endothelial cells after intense exerc...
Guidelines 1 results
https://doi.org/10.1111/1346-8138.14160
The Journal of Dermatology; Jinnin M, Yamamoto T et. al.
Dec 14th, 2017 - We established diagnostic criteria and severity classification of eosinophilic fasciitis because there is no established diagnostic criteria or widely accepted severity classification of the disease. Also, there has been no clinical guideline for ...
Clinicaltrials.gov 1 results
https://clinicaltrials.gov/ct2/show/NCT02829112
Apr 27th, 2017 - Shulman fasciitis or eosinophilic fasciitis (EF) is a rare inflammatory disease, usually benign but disabling, described by Shulman in 1974. The diagnosis is suggested by the clinic, confirmed by MRI and confirmed by histology, there really no pub...
News 11 results
https://www.mdedge.com/dermatology/article/243218/medical-dermatology/several-uncommon-skin-disorders-related-internal
Randy Dotinga
Jul 22nd, 2021 - Five of the more uncommon dermatologic disorders – sarcoidosis, Rosai-Dorfman disease, Erdheim-Chester disease, eosinophilic fasciitis, and cutaneous Crohn disease – are linked to internal diseases and may spawn misdiagnoses, a dermatologist told.
https://reference.medscape.com/viewarticle/914839
Feb 4th, 2021 - Systemic sclerosis (SSc) is a rare, heterogenous autoimmune disease characterized by sclerodermatous skin changes, vasculopathy, and involvement of the lungs and other organs. The cause of SSc is largely unknown, but both genetic and environmental...
https://reference.medscape.com/viewarticle/914839_1
Oct 9th, 2019 - Systemic sclerosis (SSc) is a noncontagious, chronic, autoimmune disease that has two principal forms: limited SSc (lSSc) or diffuse SSc (dSSc), which is typically progressive. The patient workup for SSc uses various laboratory and imaging studies...
https://www.mdedge.com/rheumatology/article/170582/pediatrics/site-morphea-lesions-predicts-risk-extracutaneous
Doug Brunk
Jul 18th, 2018 - LAKE TAHOE, CALIF. – Morphea lesions on the extensor extremities, face, and superior head are associated with higher rates of extracutaneous involvement, results from a multicenter retrospective study showed.
https://www.staging.medscape.com/viewarticle/880931_1
Jun 6th, 2017 - A 48-year-old man was referred for "stiffness" in his legs. One year before presentation, he was diagnosed with stage IV lung adenocarcinoma (EGFR exon 19 deletion) with lung metastases. He was treated with nivolumab and erlotinib and experienced ...